Hjem › Major depresjon › Massachusetts › Boston
Kliniske studier for Major depresjon i Boston, MA
31 studier for Major depresjon søker deltakere på steder i og rundt Boston (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder
RekruttererFase 3
- Adams Clinical Boston, Boston
A Phase 3 Trial of DT120 for Major Depressive Disorder (Ascend)
RekruttererFase 3
- Adams Clinical Watertown, Boston
A Study of Brenipatide in Adult Participants With Major Depressive Disorder
RekruttererFase 3
- Adams Clinical Boston, Boston
A Study of Seltorexant as Monotherapy in Adults and Elderly Participants With Major Depressive Disorder
RekruttererFase 3
- Adams Clinical Boston, Boston
A Study of Brenipatide (LY3537031) in Adult Participants With Major Depressive Disorder
RekruttererFase 3
- Adams Clinical Boston, Boston
A Study to Evaluate the Efficacy and Safety of Esketamine for Reduction of Symptoms of Major Depressive Disorder
RekruttererFase 3
- Boston Childrens Hospital, Boston
Evaluation of Efficacy and Safety of Milsaperidone as Adjunctive Therapy in Patients With Major Depressive Disorder
RekruttererFase 3
- Vanda Investigational Site, Boston
Accelerated TMS for Perinatal Depression
Rekrutterer
- Brigham and Women's Hospital, Boston
A Study to Evaluate the Efficacy and Safety of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 Study)
RekruttererFase 2
- Seaport Investigator Site, Boston
A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder (X-NOVA3)
RekruttererFase 3
- Adams Clinical Boston, Boston
A Study to Evaluate the Effectiveness of DT-101 as an Adjunctive Treatment in Patients With Depression
RekruttererFase 2
- Draig Clinical Site, Boston
Treatment ResistAnt Depression Subcallosal CingulatE Network DBS (TRANSCEND)
Rekrutterer
- Massachusetts General Hospital, Boston
- Beth Israel Deaconess Medical Center, Boston
Home-Based tDCS Treatment Of Major Depressive Disorder
Rekrutterer
- Curavit Clinical Research (virtual study site), Boston
The Effects of Psilocybin on Self-Focus and Self-Related Processing in Major Depressive Disorder
RekruttererFase 3
- Athinoula A. Martinos Center for Biomedical Imaging, Charlestown · 1 mi unna
A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder
RekruttererFase 3
- Boston Clinical Trials Llc, Boston
Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
RekruttererFase 3
- Neurocrine Clinical Site, Boston
Triage Survey for Psychiatry Research Eligibility
RekruttererObservasjonsstudie
- Adams Clinical, Boston, Boston
Mechanisms Of Orbitofrontal Stimulation in Depression
Rekrutterer
- Beth Israel Deaconess Medical Center, Boston
REVEAL Study - Diagnostic Testing for PTSD Using the Senseye Diagnostic Tool
RekruttererFase 3Frivillige helsepersonell ønskes velkommen
- Lindus Health (Virtual Study Site), Boston
Mindfulness-Based fMRI Neurofeedback for Depression
Rekrutterer
- Northeastern University, Boston
Biomarkers/Biotypes, Course of Early Psychosis and Specialty Services
RekruttererObservasjonsstudie
- Beth Israel Deaconess Medical Center, Boston
Transcranial Near Infrared Radiation and Cerebral Blood Flow in Depression - R33
Rekrutterer
- Harvard Medical School, Boston
Study of ABX-002 for the Adjunctive Treatment of Major Depressive Disorder (AMPLIFY)
RekruttererFase 2
- Autobahn Site #137, Boston
Long-Term Maintenance With Ketamine and Esketamine for Reduction of Suicide in High-Risk Patients With Depression
RekruttererFase 4
- Massachusetts General Hospital, Boston
Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
RekruttererFase 3
- Neurocrine Clinical Site, Boston
Targeting Specific Brain Networks to Treat Specific Symptoms in Depression
RekruttererFrivillige helsepersonell ønskes velkommen
- Massachusetts General Hospital, Boston
Neuroactive Steroid to Treat Depressed Mood: A Trial for People With HIV
RekruttererFase 2
- Massachusetts General Hospital, Boston
Transcranial Direct Current Stimulation (tDCS) Neuromodulation of Executive Function Across Neuropsychiatric Populations
RekruttererFrivillige helsepersonell ønskes velkommen
- Massachusetts General Hospital, Boston
Cognitive Dysfunction and Inflammation in Depression: Experimental Inhibition Via Infliximab
RekruttererFase 2
- Massachusetts General Hospital, Boston
A Study to Evaluate the Efficacy of AXS-05 Compared to Bupropion in Preventing the Relapse of Depressive Symptoms
RekruttererFase 4
- Clinical Research Site, Boston
Peripheral Neuroimmune Mechanisms of Hyperthermia
Rekrutterer
- Massachusetts General Hospital Depression Clinical & Research Program, Boston
Major depresjon-studier i andre byer
- New York City, NY36 studier
- Atlanta, GA25 studier
- Philadelphia, PA23 studier
- Orlando, FL19 studier
- Miami, FL18 studier
- Chicago, IL17 studier
- Tampa, FL17 studier
- San Diego, CA16 studier
- Houston, TX16 studier
- Little Rock, AR14 studier
- Austin, TX13 studier
- Las Vegas, NV13 studier
Andre studier i Boston
- Brystkreft112 studier
- Ikke-småcellet lungekreft90 studier
- Kreft (alle typer)85 studier
- Metastatisk kreft63 studier
- Kolorektal kreft63 studier
- Lungekreft62 studier
- Eggstokkreft61 studier
- Prostatakreft59 studier
- Depresjon52 studier
- Endometriekreft50 studier
- Hjertesvikt44 studier
- Akut myelogen leukemi44 studier
Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.